Title | Author(s) | Issue date | ???itemlist.??? |
Bacterial translocation attenuates the systemic hemodynamic improvement produced by terlipressin in patients with cirrhosis | Kalambokis, G. N.; Mouzaki, A.; Rodi, M.; Pappas, K.; Tsianos, E. V. | 24-Nov-2015 | - |
Differential effects of terlipressin on pulmonary and systemic hemodynamics in patients with cirrhosis and pulmonary hypertension: an echo study | Kalambokis, G. N.; Pappas, K.; Tsianos, E. V. | 24-Nov-2015 | - |
The edematogenic properties of insulin | Kalambokis, G. N.; Tsatsoulis, A. A.; Tsianos, E. V. | 24-Nov-2015 | - |
Effect of alpha1-blockade with doxazosin in pulmonary hypertension associated with cirrhosis | Kalambokis, G. N.; Pappas, K.; Tsianos, E. V. | 24-Nov-2015 | - |
Effects of terlipressin on water excretion after oral water load test in nonazotemic cirrhotic patients with ascites without hyponatremia | Kalambokis, G. N.; Pappas, K.; Baltayiannis, G.; Katsanou, A.; Tsianos, E. V. | 24-Nov-2015 | - |
Haemodynamic and renal effects of tadalafil in patients with cirrhosis | Kalambokis, G. N.; Kosta, P.; Pappas, K.; Tsianos, E. V. | 24-Nov-2015 | - |
Multiple myeloma presenting with an acute bacterial infection | Kalambokis, G. N.; Christou, L.; Tsianos, E. V. | 24-Nov-2015 | - |
Raised sympathetic activity and blood ammonia could increase sensitivity to infections in patients with cirrhosis and refractory ascites who are using beta-blockers | Kalambokis, G. N.; Tsianos, E. V. | 24-Nov-2015 | - |
Renal function impairment in patients with cirrhosis having pulmonary hypertension | Kalambokis, G. N.; Fotopoulos, A.; Pappas, K.; Tsianos, E. V. | 24-Nov-2015 | - |
Rifaximin Improves Systemic Hemodynamics and Renal Function in Patients With Alcohol-Related Cirrhosis and Ascites | Kalambokis, G. N.; Mouzaki, A.; Rodi, M.; Pappas, K.; Fotopoulos, A.; Xourgia, X.; Tsianos, E. V. | 24-Nov-2015 | - |
Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia | Kalambokis, G. N.; Mouzaki, A.; Rodi, M.; Tsianos, E. V. | 24-Nov-2015 | - |
Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis | Kalambokis, G. N.; Tsianos, E. V. | 24-Nov-2015 | - |
Serum interleukin 6 levels and cirrhosis-associated pulmonary hypertension | Kalambokis, G. N.; Mouzaki, A.; Rodi, M.; Pappas, K.; Korantzopoulos, P.; Tsianos, E. V. | 24-Nov-2015 | - |
Vasoconstrictor therapy for patients with cirrhosis with ascites but without hepatorenal syndrome | Kalambokis, G. N.; Tsianos, E. V. | 24-Nov-2015 | - |